Gentex Corporation was downgraded from Buy to Hold after missing Q3 revenue and EPS estimates and lowering its 2024 guidance. The company faces pressure on gross margins due to rising costs and an unfavorable product mix. Its 2027 revenue target of $2.8–$2.9 billion is seen as optimistic, relying heavily on new platform launches and external wins. The stock trades at a mid-level valuation compared to peers, with a revised price target of $19.80 indicating limited near-term upside and a potential 4% downside.
Gentex Corporation shares face pressure amid recent downgrades. For readers following Consumer Cyclical stocks, here is Pluang's market snapshot as of Oct 26, 2026 21:41 WIB: Out of 134 priced US Consumer Cyclical stocks, 85 rose and 46 fell today. Notable movers include FIVE at USD 232.25 (+4.04%), ANF at USD 161.28 (+3.62%), and WYNN at USD 75.30 (+3.53%).
Vallourec, a French company, released its monthly update on the total number of voting rights and shares comprising its share capital as of September 30, 2026. The company reported 267,165,720 outstanding shares with a net total of 265,283,859 voting...
Vallourec released its monthly report detailing the total number of shares and voting rights composing its share capital as of September 30, 2026. The company disclosed 267,165,720 shares in circulation with 265,283,859 net voting rights exercisable ...
The colorectal cancer market is projected to expand steadily through 2036, driven by rising global incidence and increased disease awareness. Advances in targeted therapies, immunotherapies, and biomarker-based treatments are reshaping patient care. ...
Smithfield Foods has created a $250,000 Future Leaders Scholarship program at Christopher Newport University to support eight incoming business students with $7,500 annual scholarships renewable for up to four years. The program aims to help local st...
E-Power Inc.'s joint venture, Sunrise Guizhou, received RMB 110 million of a planned RMB 200 million capital increase, raising its registered capital and valuing the company at RMB 2 billion post-money. The funds will support business expansion, R&D,...
